Business Segments · Other segment expense
Reportable Segment — Other segment expense
Biogen Reportable Segment — Other segment expense decreased by 24.3% to $317.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 10.4%, from $353.90M to $317.00M. Over 3 years (FY 2022 to FY 2025), Reportable Segment — Other segment expense shows an upward trend with a 91.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityVolatile
First reportedQ1 2022
Last reportedQ1 2026
How to read this metric
An increase often signals one-time charges or operational inefficiencies, while a decrease suggests improved cost management.
Detailed definition
This captures miscellaneous operational costs associated with the segment that are not classified as R&D or SG&A, such a...
Peer comparison
Often categorized as 'Other Operating Expenses' or 'Special Items' in peer financial disclosures.
Metric ID:
biib_segment_reportable_segment_other_segment_expenseHistorical Data
17 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $53.38M | $53.38M | $53.38M | $53.38M | $282.35M | $282.35M | $282.35M | $282.35M | $320.50M | $267.60M | $307.50M | $392.20M | $353.90M | $376.30M | $360.80M | $418.50M | $317.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +429.0% | +0.0% | +0.0% | +0.0% | +13.5% | -16.5% | +14.9% | +27.5% | -9.8% | +6.3% | -4.1% | +16.0% | -24.3% |
| YoY Change | — | — | — | — | +429.0% | +429.0% | +429.0% | +429.0% | +13.5% | -5.2% | +8.9% | +38.9% | +10.4% | +40.6% | +17.3% | +6.7% | -10.4% |
Range$53.38M – $418.50M
CAGR+56.1%
Avg YoY Growth+141.3%
Median YoY Growth+17.3%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Biogen's reportable segment — other segment expense?
- Biogen (BIIB) reported reportable segment — other segment expense of $317.00M in Q1 2026.
- How has Biogen's reportable segment — other segment expense changed year-over-year?
- Biogen's reportable segment — other segment expense decreased by 10.4% year-over-year, from $353.90M to $317.00M.
- What is the long-term trend for Biogen's reportable segment — other segment expense?
- Over 3 years (2022 to 2025), Biogen's reportable segment — other segment expense has grown at a 91.9% compound annual growth rate (CAGR), from $213.50M to $1.51B.
- What does reportable segment — other segment expense mean?
- Miscellaneous operational expenses specific to the business segment that fall outside of core R&D and administrative categories.